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Differential Activation of Individual Subunits
in Heteromeric Kainate Receptors
macroscopic physiology of AMPA and kainate recep-
tors. A significant advance in understanding the mecha-
nistic basis for AMPA receptor function was made in
Geoffrey T. Swanson,1,5 Tim Green,2 Ryuichi Sakai,3
Anis Contractor,4 Wesley Che,4 Hisao Kamiya,3
and Stephen F. Heinemann4
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channel conductance levels observed for native andUniversity of Texas Medical Branch
recombinant AMPA receptors arose from a concentra-301 University Boulevard
tion-dependent activation of individual subunits com-Galveston, Texas 77555
prising the multimeric receptors (Rosenmund et al.,2Department of Pharmacology and Therapeutics
1998; Smith and Howe, 2000). Surprisingly, the sameUniversity of Liverpool
behavior was not observed with native KARs (SmithAshton Street
and Howe, 2000), suggesting that gating mechanisms
Liverpool L69 3GE in AMPA and KARs might differ fundamentally.
United Kingdom In contrast to AMPA receptors, which have relatively
3School of Fisheries Science uniform pharmacological sensitivity, KARs are formed
Kitasato University from subunits with markedly dissimilar pharmacological
Sanriku-cho, Iwate 022-0101 properties (Hollmann and Heinemann, 1994; Dingledine
Japan et al., 1999). Kainate receptors composed of GluR5,
4Molecular Neurobiology Laboratory GluR6, or GluR7 subunits form functional homomeric
The Salk Institute for Biological Studies and heteromeric channels that respond to agonists (with
10010 North Torrey Pines Road the exception of glutamate) with distinct channel kinet-
La Jolla, California 92037 ics and sensitivity (Egebjerg et al., 1991; Sommer et
al., 1992; Schiffer et al., 1997; Cui and Mayer, 1999;
Paternain et al., 2000). The KAR subunits KA-1 and KA-2
do not form functional homomeric ion channels, butSummary
rather modify the pharmacological and physiological
properties of the channel-forming KAR subunits whenNeuronal kainate receptors are assembled from sub-
coexpressed in heteromeric complexes. For example,units with dissimilar specificities for agonists and an-
GluR6/KA-2 receptors respond to the agonists AMPAtagonists. The composite biophysical behavior of
and (S)-5-iodowillardiine (5-IW), whereas homomericheteromeric kainate receptors is determined by inter-
GluR6 receptors do not contain a binding site for thesesubunit interactions whose nature is unclear. Here we
compounds and therefore are insensitive to their agonist
use dysiherbaine, a selective kainate receptor agonist, activity (Herb et al., 1992; Swanson et al., 1998).
to show that GluR5 subunits assembled in heteromeric This “conferring” of novel pharmacological sensitivity
GluR5/KA-2 kainate receptor complexes can gate cur- by the KA-2 subunit has not been explained mechanisti-
rent without concomitant activation of their partner cally. At least two models may be imagined. First, inter-
KA-2 subunits. A long-lasting interaction between dys- subunit interactions may physically alter the binding do-
iherbaine and GluR5 subunits elicits a tonic current main of normally insensitive GluR6 subunits to create a
from GluR5/KA-2 receptors; subsequent cooperative novel binding site (e.g., for AMPA or 5-IW). This alteration
gating of KA-2 subunits can be elicited by both ago- then would allow all the subunits within the receptor
nists, such as glutamate, and some classically defined complex to respond to the agonist. Alternatively, GluR6
may remain insensitive, with the current observed duringantagonists, such as CNQX. This study demonstrates
activation of GluR6/KA-2 receptors arising solely fromthat each type of subunit within a heteromeric kainate
binding and gating of KA-2 subunits. This second hy-receptor contributes a distinct conductance upon acti-
pothesis requires that kainate receptor gating occursvation by agonist binding, and therefore provides in-
in a way similar to that of AMPA receptors; that is, itsight into the biophysical function of ionotropic gluta-
postulates gating by individual receptor subunits. Wemate receptors.
have obtained evidence to support the latter model. In
this report, we use a highly selective KAR agonist, theIntroduction
marine toxin dysiherbaine (DH), and site-directed muta-
genesis of KAR subunits to demonstrate preferential
Ionotropic glutamate receptors are multimeric channel-
activation of only the GluR5 subunits within a hetero-
forming proteins that exhibit complex physiological be- meric GluR5/KA-2 KAR complex. These results there-
havior upon activation by receptor agonists. In AMPA fore support the idea that occupancy of binding sites
and kainate receptors (KARs), each subunit within a on individual KAR subunits activates distinct channel
receptor complex is thought to have a binding site for conductance and kinetic properties.
glutamate formed from two discontinuous regions of
the subunit protein (Stern-Bach et al., 1994; Armstrong Results
et al., 1998). Until recently, it has been difficult to deter-
mine how the occupancy of binding sites on individual Dysiherbaine Is a High-Affinity Agonist
receptor subunits correlated with the single-channel and for Homomeric Kainate Receptors
Dysiherbaine (DH) was characterized previously as a
potent epileptogenic amino acid that activates both5Correspondence: g.swanson@utmb.edu
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Figure 1. Activity of Dysiherbaine (DH) on Homomeric and Heteromeric Kainate Receptors
(A) DH acts as an agonist on homomeric GluR5 (left trace) and GluR6 (right trace) kainate receptors expressed in HEK293 cells. DH (100 M)
was applied for 1 s. (B) Time course of recovery of glutamate-activated currents after application of DH. Traces show representative currents
during 100 ms applications of glutamate (“control,” 10 mM, gray bars), 5 s applications of DH (10 M), and glutamate again 20 min after DH
application. Glutamate currents were evoked from GluR5 (top), GluR6 (center), and GluR6/KA-2 (bottom) receptors. (C) The graph shows the
percent peak amplitudes of test glutamate currents normalized to the initial control amplitudes (before application of DH) for the experiments
shown in (B) (GluR5, closed squares; GluR6, open squares; GluR6/KA-2, open triangles. (D) The histogram shows the averaged data for the
normalized amplitude of the peak glutamate currents 5, 10, or 30 min after application of DH. Columns show mean  SEM.
AMPA and kainate receptors in cultured neurons (Sakai siently expressed in HEK293 cells. DH (100 M) evoked
desensitizing inward currents from cells expressing ho-et al., 2001). Additionally, in radioligand binding assays,
DH was shown to displace [3H]kainate from recombinant momeric GluR5 or GluR6 kainate receptors (Figure 1A).
These results also suggested that the interaction be-GluR5 or GluR6 receptors with very high affinity. In our
current experiments, we initially determined the activity tween DH and the homomeric receptors was of particu-
larly high affinity, because application of DH desensi-of DH on recombinant kainate receptors formed from
the subunits GluR5, GluR6, KA-1, and KA-2. We first tized the receptor for extended periods. To investigate
the time course of the interaction between DH and kai-examined currents elicited by DH on recombinant
GluR5, GluR6, and GluR6/KA-2 kainate receptors tran- nate receptors, we measured the recovery of responses
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evoked by glutamate after an application of DH (Figures DH), these data demonstrate that high-affinity DH inter-
action with one type of binding site gives rise to the tonic1B and 1C). After initial control glutamate applications
(10 mM, 100 ms), DH (10 M) was applied for 1 s; this current, whereas a distinct binding domain(s) remain
accessible to glutamate.was followed by further glutamate applications at 20 s
intervals. Representative glutamate and DH currents are
shown in Figure 1B. The time courses of recovery of A Model for the Action of Dysiherbaine
glutamate-activated currents are shown normalized to on GluR5/KA-2 Receptors
control amplitudes in Figure 1C. Prior DH application We developed a model to provide a mechanistic expla-
irreversibly and completely occluded any subsequent nation for our results (Figure 2E). This model proposes
activation of homomeric GluR5 receptors by glutamate that GluR5/KA-2 receptors can be activated at two phar-
for at least 45 min. DH produced a similar but less pro- macologically separable sites. Note that while the model
found blockade of glutamate-evoked currents mediated accounts for the actions of DH on heteromeric GluR5/
by GluR6 receptors, which returned to 32%  14% of KA-2 receptors, our initial experiments did not allow us
pre-DH amplitudes after 30 min (n  3). In contrast, to come to any conclusions regarding the location of
heteromeric GluR6/KA-2 receptors recovered to 90.4% sites on the receptor subunits. The proposed relation-
6.4% of pre-DH amplitudes 5 min after application of ship between DH and glutamate currents and the occu-
DH (n  5). The recovery of glutamate currents relative pancy of these binding sites is shown in the cartoon
to control amplitudes for these kainate receptors at se- in Figure 2E. Initial DH binding to both sites results in
lected time points after DH application is summarized transient activation (state 1) and desensitization of the
in Figure 1D. The most straightforward interpretation of receptor (state 2). After removal of DH, it continues to
this data is that DH forms an extremely stable closed- bind to the high-affinity site (represented by the green
channel complex with homomeric kainate receptors, but box), which produces the prolonged steady-state cur-
not heteromeric GluR6/KA-2 kainate receptors. rent (state 3). The second, lower affinity binding site
(pink box) remains available to interact with agonists,
resulting in transient activation (state 4) and completeComponent Subunits in Heteromeric GluR5/KA-2
Receptors Respond Differently to Dysiherbaine desensitization of the entire receptor complex (state 5).
After removal of agonist, the receptor returns to state 3,In contrast to the three types of kainate receptors shown
in Figure 1 (GluR5, GluR6, and GluR6/KA-2), DH elicited in which stably bound DH continues to elicit the steady-
state current (e.g., Figure 2D).complex channel behavior from heteromeric GluR5/
KA-2 receptors (Figure 2). Glutamate currents arising We consider four observations to be supporting evi-
dence for presence of multiple functional sites as shownfrom GluR5/KA-2 receptors before application of DH
(“control”) were rapidly desensitizing (des of 2.1  0.1 in Figure 2E. First, activation of the receptor during the
DH steady-state current by glutamate or other agonistsms, n  20, Figure 2A). Subsequent application of 10
M DH evoked a desensitizing inward current (des of does not compete with and displace the high-affinity
DH binding that gives rise to the tonic current. Second,349  85 ms, n  9). Surprisingly, a long-lasting inward
current slowly developed when cells were returned to the high-affinity site can be selectively activated with a
very low concentration of DH (100 nM), which producescontrol solution (Figure 2B). The long-lasting current
consistently arose after removing DH from the bathing a slowly rising steady-state current without the desensi-
tization apparent at higher agonist concentrations (datasolution—regardless of the duration of the DH applica-
tion. This tonic current had a time course of activation not shown). Third, GluR5/KA-2 receptors can be further
activated during the prolonged DH current. Glutamate(after removal of DH) of 25.2  2.9 s (n  9) and a mean
amplitude of 48 11 pA (range 9–199 pA, n 17), which application in the presence of the stable DH current
invariably evoked a small inward current before the on-was 32%  5% of the peak glutamate current in the
same cells. The current amplitude typically decayed set of desensitization (see Figure 2C, illustrated as ele-
ment “4” in Figure 2E). This transient inward current hadback to baseline levels after 10 to 20 min. The presence
of the DH-induced tonic current, after removal of the a similar voltage- and glutamate concentration depen-
dency as that of the peak nondesensitized current ofagonist from the external solution, suggested that the
interaction between DH and GluR5/KA-2 receptors was the “naı¨ve” receptor (before DH application). The ampli-
tude of the transient peak current elicited by glutamatevery stable.
We then applied agonists, such as glutamate, to was 23%  3% of the peak glutamate current before
application of DH (n  14). Fourth, the rate of glutamateGluR5/KA-2 receptors after the development of the DH-
evoked tonic current. Glutamate elicited a transient in- desensitization (before DH application) and the rate of
glutamate-induced rapid “positive” displacement toward current followed by rapid reduction of the tonic DH
current to an amplitude similar to the baseline “holding” baseline amplitudes of the tonic DH current were indis-
tinguishable ( values of 2.1  0.2 ms and 2.0  0.2 ms,current before application of DH (i.e., an apparent posi-
tive displacement of the current, illustrated by the dotted n  16 and 15, respectively). We also compared the
rates of desensitization and positive displacement oflines in Figure 2C). The onset of the glutamate-induced
reduction in current was rapid (  2.1  0.2 ms, n  the DH steady-state current observed with both AMPA
(250 M) and DH (10 M) and found that these also were18). After removal of glutamate, the stable DH current
re-emerged with a time course of 22.3  1.8 s (n  5, not significantly different (AMPA:  values of 8.4  1.5 ms
for desensitization and 7.0 1.0 ms for displacement, nFigure 2D). The tonic current was similar in amplitude
before and after application of glutamate. Because glu- 4 and 3; DH:  values of 349  85 ms for desensitization
and 389  93 ms for displacement, n  9 and 8, respec-tamate did not attenuate the tonic current (by displacing
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Figure 2. GluR5/KA-2 Receptors Have Multiple Sites and Modes of Activation
(A) Glutamate (10 mM, 100 ms, gray bar) evoked a rapidly desensitizing current from GluR5/KA-2 receptors that were not exposed previously
to DH. (B) DH (10 M, 5 s, black bar) acts as an agonist on GluR5/KA-2 receptors. After cells are returned to control solution, a long-lasting
inward current slowly develops. (C) Applications of glutamate after DH suppressed the steady-state DH current back to pre-DH baseline
amplitudes. The dotted line shows the baseline current before DH application, and the dashed line shows the amplitude of the steady-state
current after DH. (D) After removal of glutamate, the steady-state DH current returns with a time course of 22 s, demonstrating that the two
activities are not competitive. (E) A hypothetical model relating occupancy of two distinct binding sites to activation and desensitization of
GluR5/KA-2 receptor complexes. Heteromeric kainate receptors composed of GluR5 and KA-2 subunits are shown as single molecules, within
the gray plasma membrane, with two distinct binding sites for DH—high- (green) and low-affinity (pink). The position of the triangular gates
within the receptor represent permeant or nonpermeant conformations of the channel. The numbered states correspond to labeled components
of the receptor currents shown in the lower left part of the panel. DH binds to both activation sites of the receptor, resulting first in channel
opening and a peak transient current (identified as 1 on the idealized DH trace below the cartoons), then a slower onset of desensitization
(state 2). After removal of DH from the bathing solution, it remains tightly bound to the high-affinity site, but not the low-affinity site, resulting
in long-lasting steady-state current (state 3). Subsequently, glutamate can bind to the available low-affinity site and cause a transient peak
current (state 4) followed by desensitization of the entire receptor complex (state 5). Upon removal of glutamate, the tonic DH current returns
as the receptors recover from glutamate desensitization, and the receptor returns to state 3.
tively). The high correlation between rates of desensiti- Independent Activation of Subunits in Other
Heteromeric Kainate Receptor Complexeszation of naı¨ve receptors and the displacement of the
tonic DH currents provides strong support for the hy- Can we detect independent activation sites in other het-
eromeric kainate receptor assemblies? As shown ear-pothesis that the current displacement arises from re-
ceptor desensitization. Thus, we conclude that the tonic lier, GluR6/KA-2 receptors exhibited a much shorter
lived interaction with DH (Figures 1B and 1C). However,DH current arises from partial activation of the hetero-
meric receptor complex; binding of agonists at a sepa- re-examination of glutamate-activated currents evoked
within 1 min of DH application revealed a small positiverate site further activates then desensitizes the re-
ceptors. displacement relative to baseline amplitudes similar to
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Figure 3. Multiple Activation Sites Are Detectable in KA-2 Subunit-Containing Receptors, and CNQX Acts as an Agonist at the Lower Affinity
Site
(A) Left panel: Examples of GluR6/KA-2 currents evoked by glutamate (10 mM) 20 s and 80 s after application of DH. Right panel: on an
expanded scale, a positive displacement of the current is evident at the earlier time point after DH application. The DH-activated steady-state
current decays rapidly with this receptor combination; consequently, the second form of activation is not detectable at 80 s. The peak
glutamate current has been removed for clarity and the baseline currents were normalized to more clearly illustrate the time-dependent
glutamate inhibition. (B) GluR5/KA-1 receptors respond to DH like homomeric GluR5 receptors. Inset traces show representative currents
from whole-cell recording during fast application of 10 mM glutamate before (control) and at 30 min after application of DH (10 M, 1 s, black
bar). DH evokes a very small inactivating current from GluR5/KA-1 receptors, but subsequent glutamate applications do not elicit detectable
peak currents. The graph shows the relative peak amplitudes of the glutamate current normalized to the initial control amplitudes for the
experiment shown in the current traces. (C) CNQX acts as an agonist at the lower affinity binding site. Representative responses to glutamate
before and after DH application are shown to illustrate the baseline and steady-state amplitudes for this recording. Application of CNQX (50
M) in the presence of the steady-state DH current elicits a nondesensitizing inward current.
that seen in GluR5/KA-2 receptors (Figure 3A). The DH- eromeric kainate receptors containing KA-1 subunits ex-
hibited the long-lasting DH current (Figure 3B). We foundactivated GluR6/KA-2 current was detectable only for a
brief period of time (1 min), presumably reflecting the that, in contrast to GluR5/KA-2 receptors, GluR5/KA-1
receptors were irreversibly inactivated by DH (Figuremore rapid dissociation of DH from the high-affinity acti-
vation site of this heteromeric receptor. These experi- 3B). A prolonged steady-state current was not observed.
Less than 10% recovery of glutamate currents was ob-ments demonstrate that DH differentiates multiple acti-
vation sites in receptors containing either GluR5 or served for up to 30 min after application of DH (n  4).
We conclude that domains found on the KA-2 subunit,GluR6 subunits with the KA-2 subunit.
The KA-2 subunit is highly homologous to the KA-1 but not the KA-1 subunit, interact with GluR5 subunits
to produce DH-induced tonic current.receptor subunit (Werner et al., 1991; Herb et al., 1992),
and these receptor subunits confer similar functional
properties when assembled with the channel-forming CNQX Acts as an Agonist on KA-2 Receptors
We tested whether the well-characterized antagonistsubunits GluR5, GluR6, or GluR7 (Herb et al., 1992; Partin
et al., 1993; Schiffer et al., 1997). We next tested if het- CNQX could occlude the action of glutamate on the
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GluR5/KA-2 lower affinity site (after application of DH). GluR6 (data not shown). These data demonstrate that
residue 721 on GluR5 and GluR6 is likely to be a primarySurprisingly, in the presence of the DH tonic current,
application of 50 M CNQX elicited a reversible nonde- determinant of receptor gating following DH binding to
the high-affinity site on heteromeric kainate receptors.sensitizing inward current with a mean amplitude of 24
7 pA (n  6, Figure 3C). No CNQX-activated current was We also made mutations in the KA-2 subunit to deter-
mine if interactions with threonine 705, the KA-2 equiva-observed before application of DH (data not shown), nor
did application of 0.25% DMSO, the solvent used for lent of asparagine 721 in GluR6, influenced the lower
affinity response to glutamate or CNQX. The corre-CNQX, elicit a current after exposure to DH. DNQX, a
closely related analog of CNQX, elicited similar currents sponding residue was shown to interact directly with
DNQX in a GluR2 S1S2 crystal structure (Armstrong andfrom GluR5/KA-2 receptors (data not shown). These
data therefore show that under some conditions, CNQX Gouaux, 2000). Two substitutions, to an asparagine
(KA2(T705N)) or a serine (KA2(T705S)), were made foris an agonist for GluR5/KA-2 receptors.
threonine 705, and the resultant KA2 mutants were ex-
pressed in combination with GluR5 subunits. The gluta-Identification of Receptor Subunits that Form
mate desensitization rate was unaffected by these muta-the High- and Low-Affinity Binding Sites
tions, and GluR5/KA2(T705S/N) receptor assembliesfor Dysiherbaine
responded to DH with the prolonged current after re-The model in Figure 2 proposes two distinct activation
moval of the agonist. We tested both combinations ofsites in GluR5/KA-2 receptors that can be differentiated
heteromeric receptors for sensitivity to CNQX, andby the agonist DH, but does not identify which subunits
found that while it elicited a nondesensitizing currentwithin the heteromeric receptor complex contribute the
from GluR5/KA-2(T705S) receptors, GluR5/KA-2(T705N)high- and low-affinity binding sites. We next attempted
receptors were insensitive to CNQX (n  4, Figure 4C).to refine our model by testing the hypothesis that the
Receptors comprised of two mutant subunits, R6(N721S)/two functional binding sites were formed from the S1-
KA2(T705N), were similarly insensitive to CNQX (n  3).S2 binding domains of the individual kainate receptor
Furthermore, GluR5/KA2(T705N/S) receptors “recov-subunits, as is the case for other AMPA and kainate
ered” to the tonic DH current amplitude more rapidlyreceptor subunits (Stern-Bach et al., 1994; Armstrong
after application of glutamate. This rate was 1.8  0.2et al., 1998; Abele et al., 1999; Armstrong and Gouaux,
s for GluR5/KA-2(T705N) (n  5) and 8.4  1.5 s for2000). Because of the marked difference in the dura-
GluR5/KA-2(T705S) receptors (n  5) (compared totion of the steady-state DH current between GluR5/KA-2
22.3 s for GluR5/KA-2 receptors). There were no appar-and GluR6/KA-2 receptors, we postulated that the high-
ent differences in the durations of the steady-state DHaffinity DH binding site resided on GluR5 subunits,
current with the KA-2 mutants. In summary, these datawhereas the low-affinity DH binding site (at which CNQX
support the interpretation that KA-2 is the subunit onacts as agonist) is formed by the KA-2 subunit. To ex-
which CNQX acts as an agonist and localize residue 705plore the contributions of individual subunits to the be-
as one important determinant of KA-2 current kinetics.havior of the GluR5/KA-2 receptor, we made use of site-
directed mutants of kainate receptor subunits (Swanson
Binding Studies Support the Existence of High-et al., 1997).
and Low-Affinity DH Binding SitesSubstitution of a serine for an asparagine in the GluR6
Our model postulates that GluR5/KA-2 receptors con-subunit at residue 721 (mutant R6(N721S)) produces
tain two binding sites with markedly different affinitiesa receptor that responds to some agonists with the
for DH. Previously, we reported that DH displacedpharmacology of a GluR5 receptor (Swanson et al.,
[3H]kainate binding to GluR5 receptors with a Ki value1997). Similarly, we found that homomeric and hetero-
of 0.5 nM (Sakai et al., 2001). In similar experiments tomeric receptors containing the R6(N721S) subunit re-
determine the DH binding affinity for the KA-2 subunit,sponded to DH as though they contained GluR5 receptor
we found that DH displaced [3H]kainate with a signifi-subunits (Figure 4A). Currents evoked by glutamate from
cantly higher Ki value of 4.3  0.8 M (n  5, Figurehomomeric R6(N721S) receptors previously exposed to
4D). These data show that the DH binding affinity forDH (10 M, 1 s) showed no recovery of glutamate-
GluR5 and KA-2 subunits differs by at least four ordersevoked currents for up to 30 min (3.4% 1.8% of control
of magnitude, and support the interpretation that thecurrent amplitudes, n  4). Application of DH to hetero-
functionally observed high- and low-affinity sites for DHmeric R6(N721S)/KA-2 receptors elicited a desensitizing
reside on the GluR5 and KA-2 subunits, respectively.inward current followed by a prolonged steady-state
current after removal of DH, similar to GluR5/KA-2 re-
ceptors (Figure 4A). The time courses of the actions of Discussion
DH and glutamate on R6(N721S)/KA-2 receptors were
similar to those of GluR5/KA-2 receptors; for example, By virtue of its unusually high affinity for a subset of
kainate receptor subunits, DH provides insight into thedesensitization rates of R6(N721S)/KA-2 receptors upon
application of glutamate or DH (des of 2.6  0.1 and biophysical operation of this family of ionotropic gluta-
mate receptors. The action of DH on GluR5/KA-2 and331  52 ms, n  16 and 11, respectively) were similar
to that of GluR5/KA-2 receptors. Finally, in the presence GluR6/KA-2 receptors, together with site-directed muta-
genesis of the receptor subunits, provides support forof the stable DH-induced current, CNQX evoked a non-
desensitizing current from R6(N721S)/KA-2 receptors a model of receptor function in which individual subunits
can be activated within the multimeric receptor com-(23  7 pA, n  3, Figure 4B). Similar results were ob-
served when a threonine was substituted for N721 in plex. Thus, agonists for heteromeric kainate receptors
Selective Activation of Kainate Receptor Subunits
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Figure 4. Localization of the High- and Low-
Affinity Binding Sites to GluR5 and KA-2 Sub-
units, Respectively, Using Site-Directed Mu-
tagenesis
(A) A site mutation of the GluR6 subunit con-
verts the DH sensitivity to that of GluR5 re-
ceptors. Heteromeric R6(N721S)/KA-2 recep-
tors exhibit rapidly desensitizing responses
to glutamate (100 ms, 10 mM, left trace). DH
application (10 M, 5 s) elicits a long-lasting
steady-state current like that of GluR5/KA-2
receptors (center trace). The amplitude of the
steady-state DH current was 150  34 pA
(n  16). In the presence of the steady-state
DH current, glutamate elicits a transient peak
current and then desensitizes the entire re-
ceptor complex (right trace). (B) After treat-
ment with DH, CNQX (50 M) and DNQX (50
M) elicited inward currents from R6(N721S)/
KA-2 receptors. (C) Mutation of threonine 705
to an asparagine in the KA-2 subunit eliminates
CNQX agonist activity. Glutamate evokes
currents that rapidly desensitize with time
course identical to that of GluR5/KA-2 recep-
tors (left trace). After application (and re-
moval) of DH, the steady-state current re-
sulting from continued occupation of the
high-affinity binding site develops, and sub-
sequent applications of glutamate desensi-
tize the GluR5/KA2(T705N) receptors (center
trace). Application of CNQX (50 M) does not
evoke an inward current (right trace). (D) Dis-
placement of [3H]kainate binding from mem-
branes containing KA-2 receptor subunits. A
range of concentrations of DH was used to
displace [3H]kainate from KA-2 subunits. The
Ki value was calculated as 4.9 M for the
example shown. DH displacement of [3H]kai-
nate from GluR5 subunits is shown for the
sake of comparison and is taken from Sakai
et al. (2001).
will elicit currents whose kinetic properties are depen- toon from Figure 2 with experimentally defined binding
sites localized to subunit proteins. We propose that thedent on the efficacy of activation of each type of compo-
nent subunit in the receptor complex as well as the high-affinity binding site for the agonist DH resides on
the GluR5 subunit (or GluR6 subunits mutated at residuedegree to which kinetic parameters are dominated by
a particular receptor subunit. Kainate receptor subunits 721) and the low-affinity site is formed by the KA-2 sub-
unit. While this model, in which the high- and low-affinityare heterogeneous in their pharmacological specific-
ities, as evidenced by the unusual responses to DH, and binding domains are contained within individual sub-
units, represents the most straightforward interpretationtherefore this model has implications for the design of
drugs that target kainate receptors in the CNS. of our mutagenesis results, we recognize that possibili-
ties that are more complex could be imagined. The pro-The model of receptor function that incorporates our
site-directed mutagenesis and binding results is de- longed current after DH application arises from contin-
ued occupation of the high-affinity agonist binding sitetailed in Figure 5. It represents an extension of the car-
Figure 5. A Cartoon Extending Our Model
from Figure 2 to Incorporate Results from
Site-Directed Mutagenesis of the GluR5/6
Subunits (at Residue 721) and KA-2 Subunits
(at Residue 705)
Tonic current from GluR5/KA-2 receptors re-
sults from stable binding to and selective ac-
tivation of GluR5 subunits by DH. Subsequent
binding by glutamate to the low-affinity site
on KA-2 subunits causes a small transient
inward current, followed by a desensitization
of the entire GluR5/KA-2 receptor complex
(see idealized currents in Figure 2E). CNQX
acts as an agonist on the KA-2 subunit after
tonic activation of the GluR5 subunits by DH.
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on GluR5 subunits. In the presence of this prolonged and Mayer, 1999; Paternain et al., 2000). For example,
Cui and Mayer (1999) found that the currents evoked bycurrent, agonists can access the unoccupied KA-2 bind-
ing site and cause a transient current followed by desen- the GluR5-selective agonist (S)-5-iodowillardiine desen-
sitized less in GluR5/GluR6 receptors compared to ho-sitization of the entire receptor complex. Re-emergence
of the prolonged DH current is likely determined by the momeric GluR5 receptors. Similarly, Paternain and co-
workers observed that activation of heteromeric GluR5/rate of recovery from desensitization and unbinding of
agonist from the low-affinity binding site on the KA-2 KA-2, GluR6/KA-2, and GluR5/GluR6 receptors with se-
lective agonists elicited currents with differing desensiti-subunit. Most surprisingly, CNQX acts as a nondesensi-
tizing agonist on the KA-2 subunit, but only when the zation kinetics. It is possible that the complicating effect
of desensitization on the gating kinetics of heteromericGluR5 subunits first are activated by DH. The dissimilar
pharmacology of GluR5 and KA-2 subunits reveals that kainate receptors accounts for the apparently concen-
tration-independent behavior of kainate receptors in sin-each type of subunit can contribute an independent
agonist-activated conductance. gle channel recordings by Smith and Howe, as was pre-
viously suggested by these authors (Smith and Howe,Our results suggest that mechanisms of gating in kai-
nate receptors are similar to recent proposals for the 2000).
This aspect of kainate receptor function is intriguingactivation of AMPA receptors (Rosenmund et al., 1998;
Smith and Howe, 2000). Rosenmund and coworkers in light of the different pharmacological sensitivities of
the two related groups of proteins that associate to formused a nondesensitizing mutant of the GluR3 AMPA
receptor to show that the relative proportion of individual kainate receptors (GluR5/GluR6/GluR7 subunits versus
KA-1/KA-2 subunits). By inference from mRNA expres-single-channel conductance states depended on the
number of agonist molecules bound to receptor sub- sion patterns, many, if not all, neuronal kainate receptors
will contain at least one member of each group in hetero-units; for example, they observed a higher proportion
of openings to larger conductances at higher agonist meric channel complexes (the vast majority of those
will contain KA-2 rather than KA-1 subunits). We haveconcentrations. From these data, they inferred that bind-
ing of an agonist molecule to a single receptor subunit identified a compound, DH, which binds to GluR5 and
GluR6 subunits with an affinity four orders of magnitude(in a tetrameric complex) produced an associated con-
ductance; as more subunits were activated, the single- greater than its affinity for KA-2 subunits, which may
facilitate the future exploration of the subunit composi-channel conductance became larger. Subsequent ex-
amination of cerebellar AMPA and kainate receptor tion of neuronal kainate receptors. Other compounds,
such as AMPA, have an inverse selectivity profile andsingle-channel currents by Smith and Howe (Smith and
Howe, 2000) supported a similar mode of operation for bind with high affinity to KA-2 subunits but with very
low affinity to GluR5 or GluR6 subunits; similarly, AMPAnative AMPA receptors. In contrast, kainate receptors
did not appear to behave in the same way, which was will elicit currents from heteromeric GluR6/KA-2 recep-
tors but not homomeric GluR6 receptors. By analogysurprising considering their structural and functional
similarity to AMPA receptors. Single-channel conduc- with our understanding of how we think DH interacts
with KARs, AMPA would be selectively activating KA-2tance states did not correlate with agonist concentra-
tion, suggesting that kainate receptors (in cerebellar subunits to produce currents from GluR6/KA-2 re-
ceptors.granule neurons) might have a gating mechanism dis-
tinct from that of AMPA receptors. In our study, the CNQX provides a third, more unusual example of se-
lective activity on heteromeric GluR5/KA-2 receptors. Indifferential pharmacological profile of kainate receptor
subunits allowed us to demonstrate at a macroscopic this case, the compound acts as an antagonist on one
subunit, GluR5, but as an agonist on the partner KA-2level that these receptors have subunit-associated con-
ductances. Therefore, AMPA and kainate receptors are subunits. The observation that agonist activity was elim-
inated by changing a single amino acid in the KA-2likely to share a common gating mechanism.
While our data demonstrate that activation of a subset subunit, T705, as well as earlier results in which CNQX
was shown to be a potent agonist on recombinant GluR1of subunits can occur within a heteromeric receptor
complex, other aspects of channel gating, in particular AMPA receptors containing the Lurcher mutation
(A636T) (Taverna et al., 2000), underscore the conclusiondesensitization, are dependent on interaction between
subunits. The observation that DH produces a sustained that single amino acids critical for receptor gating can
determine how receptor ligands are defined pharmaco-current from GluR5/KA-2 but not homomeric GluR5 re-
ceptors demonstrates that the gating of the GluR5 sub- logically. We note, however, that the CNQX agonist ac-
tivity thus far is detectable only under a rather unusualunits (in heteromeric receptors) is influenced by the
presence of KA-2 subunit. The location of the domains set of conditions—previous activation of partner GluR5
subunits. Two possible explanations may account foron KA-2 that effect the change in GluR5 kinetics is un-
known, although it is worth noting that many residues the absence of a CNQX-evoked current before applica-
tion of DH: first, the antagonist activity of CNQX onthat alter desensitization in AMPA and kainate receptors
are located in regions that may form intersubunit inter- GluR5 subunits may “lock” the heteromeric receptors
in a state unfavorable for gating, and thus dominate thefaces (Armstrong and Gouaux, 2000). Glutamate desen-
sitization of the DH tonic current in GluR5/KA-2 recep- agonist activity on KA-2 subunits. Alternatively, KA-2
subunits in heteromeric receptors may require coopera-tors demonstrates that agonist binding to one subunit
can produce a dominant desensitization of distinct sub- tive activation of GluR5 subunits before agonist binding
can elicit gating. Site-directed mutations on GluR5 orunits in the heteromeric complex. Related observations
were made in previous studies that examined the phar- KA-2 that selectively eliminate the affinity for CNQX may
distinguish between these possibilities.macological properties of GluR5/GluR6 heteromers (Cui
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